Atlas Trials

Busulfan and Fludarabine in Patients With AML and MDS

Clinical trial NCT00502905 · COMPLETED

Trial details

NCT number
NCT00502905
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2003-10-01
Primary completion
2008-11-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.